Kun for helsepersonell

Viktig sikkerhets-og forskrivningsinformasjon: Breyanzi® (lisocabtagene maraleucel)

image

From Clinical Study To Clinical Practice with CAR-T

Interview: 9 minutes

Professor Stephan Mielke, department of hematology and cell therapy at Karolinska university hospital in Stockholm, shares insights from their CAST team, what patients are appropriate for CAR-T, the journey from participating in clinical trials to clinical practice with CAR-T and how the treatment landscape in 2nd and 3rd line is changing in DLBCL.

 

Related videos

How to become a CAR-T treatment centra
How can we improve outcomes for patients with R/R LBCL?

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

 

HE-SE-2500012 Oct 2025 video/ 2009-NO-2500020 Dec 2025